Based on recent data, Vertex Pharmaceuticals Incorporated (VRTX) shows an Average True Range (ATR) of 12.28 and an Enterprise Value of 93.96B. Its average trading volume over the past 3 months is 1.36M, indicating liquidity. These fundamental metrics provide insight into VRTX's underlying financial health and market activity.
| ATR | 12.28 |
| Enterprise Value | 93.96B |
| Avg Vol (3 Months) | 1.36M |
| Avg Vol (10 Days) | 1.2M |
Vertex Pharmaceuticals Incorporated (VRTX) technical indicators as of February 6, 2026: the SMA 20 is -0.89%, SMA 50 at 0.77%, and SMA 200 at 5.17%. The RSI 14 value is 47.81, suggesting its current momentum. These technical analysis signals help assess VRTX's price trends and potential future movements.
| SMA 20 | -0.89% |
| SMA 50 | 0.77% |
| SMA 200 | 5.17% |
| RSI 14 | 47.81 |
Vertex Pharmaceuticals Incorporated (VRTX) stock performance overview as of February 6, 2026: The 52-week high is $519.68 (currently -11.71% below), and the 52-week low is $362.5 (currently 26.57% above). Over the past year, VRTX's performance is 6.02%, compared to the S&P 500's 8.96% change.
| 52-Week High | 519.68 |
| 52-Week High Chg | -11.71% |
| 52-Week Low | 362.5 |
| 52-Week Low Chg | +26.57% |
| S&P 500 52-Week Chg | 8.96% |
According to market data, Vertex Pharmaceuticals Incorporated (VRTX) stock's recent performance metrics show that over the last month, VRTX is -1.66%, with a Year-to-Date (YTD) performance of -2.49%. Over the past year, the stock has seen a 6.02% change. These figures summarize VRTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 478.72 | 487.52 | 487.52 | 487.52 | 519.68 | 487.52 |
| Low | 457.74 | 429 | 403.16 | 362.5 | 362.5 | 429 |
| Performance | -4.02% | -1.66% | +6.06% | -3.58% | +6.02% | -2.49% |
According to current financial data, VRTX stock's P/E (TTM) ratio is 31.89, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for VRTX, including P/S (10.03), P/B (6.77), and P/FCF (35.22), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VRTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 31.89 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 10.03 | 3.71 | 464.72 | 5.98 |
| P/B (TTM) | 6.77 | 2.98 | 8.93 | 5.45 |
| P/FCF (TTM) | 35.22 | -11.69 | -192.01 | 31.94 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep